COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
Study Information
Study Attribute Value
CEBS Accession Number: 002-03165-0002-0000-9
Chemical Name: p-Cresidine
CASRN: 120-71-8
NTP Study Type: Genetic Toxicology - Mammalian Cell Cytogenetics
NTP Study ID: 459789_CA
Study Result: Weakly Positive

Study Result: Weakly Positive
Activation Trial Trial Call
No Activation  Negative 
Induced Rat Liver S9  1_S9  Weakly Positive* 
Induced Rat Liver S9  2_S9  Weakly Positive* 

Trial #:1   Activation: No Activation    Date: 03/12/1987    Harvest Time: 12 hour(s)   Trial Call: Negative   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Dimethyl Sulfoxide
0         
200 1 0.005 0.5 0 0.000 0.0 1 0.005 0.5 0 0.000 0.0
Test Chemical: p-Cresidine
300         
200 1 0.005 0.5 1 0.005 0.5 0 0.000 0.0 0 0.000 0.0
500         
200 4 0.020 2.0 0 0.000 0.0 4 0.020 2.0 0 0.000 0.0
1000         
200 2 0.010 1.0 0 0.000 0.0 2 0.010 1.0 0 0.000 0.0
Positive Control: Mitomycin-C
 0.0625    
200 45 0.225 20.0 13 0.065 6.5 32 0.160 14.5 0 0.000 0.0
Mitomycin-C
 0.25      
50 19 0.380 34.0 4 0.080 8.0 15 0.300 28.0 0 0.000 0.0
Trend: 0.869 -0.419 1.087  
Probability: 0.192 0.662 0.138  


Trial #:1_S9   Activation: Induced Rat Liver S9    Date: 03/12/1987    Harvest Time: 13 hour(s)   Trial Call: Weakly Positive*   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Dimethyl Sulfoxide
0         
200 1 0.005 0.5 0 0.000 0.0 1 0.005 0.5 0 0.000 0.0
Test Chemical: p-Cresidine
300         
200 2 0.010 0.5 0 0.000 0.0 2 0.010 0.5 0 0.000 0.0
500         
200 3 0.015 1.5 0 0.000 0.0 3 0.015 1.5 0 0.000 0.0
1000         
200 12 0.060 6.0 3 0.015 1.5 9 0.045 4.5 0 0.000 0.0
Positive Control: Cyclophosphamide
2.5       
200 46 0.230 20.0 12 0.060 6.0 34 0.170 16.5 0 0.000 0.0
Cyclophosphamide
7.5       
50 21 0.420 38.0 7 0.140 14.0 14 0.280 26.0 0 0.000 0.0
Trend: 3.932 2.420 3.197  
Probability: 0.000 0.008 0.001  


Trial #:2_S9   Activation: Induced Rat Liver S9    Date: 04/29/1987    Harvest Time: 13 hour(s)   Trial Call: Weakly Positive*   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Dimethyl Sulfoxide
0         
200 2 0.010 1.0 0 0.000 0.0 2 0.010 1.0 0 0.000 0.0
Test Chemical: p-Cresidine
300         
200 5 0.025 1.5 0 0.000 0.0 5 0.025 1.5 0 0.000 0.0
500         
200 6 0.030 2.0 3 0.015 0.5 3 0.015 1.5 0 0.000 0.0
1000         
200 17 0.085 7.0 5 0.025 2.0 12 0.060 5.0 0 0.000 0.0
Positive Control: Cyclophosphamide
2.5       
200 35 0.175 15.0 8 0.040 4.0 27 0.135 11.5 0 0.000 0.0
Cyclophosphamide
7.5       
50 33 0.660 36.0 9 0.180 12.0 24 0.480 32.0 0 0.000 0.0
Trend: 3.600 2.659 2.643  
Probability: 0.000 0.004 0.004